Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: A nationwide population-based study
- S. H. Chien
- , C. J. Liu*
- , Y. C. Hong
- , C. J. Teng
- , Y. W. Hu
- , C. C. Shen
- , F. C. Ku
- , S. C. Chen
- , C. M. Yeh
- , T. J. Chiou
- , J. P. Gau
- , C. H. Tzeng
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations